Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.22 -0.11 (-0.32%)
Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
News headline image
Why Teva Pharmaceutical Stock Is Sliding Today ↗
Investors were disappointed with the drugmaker's 2023 outlook. 
Via The Motley Fool
News headline image
Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations ↗
 
Via Benzinga
News headline image
Teva Pharmaceutical Stock Dives On Fourth-Quarter Miss, Light 2023 Guidance ↗
The company missed fourth-quarter estimates and issued light guidance. 
Via Investor's Business Daily
News headline image
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026 ↗
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite. 
Via The Motley Fool
News headline image
The 7 Best Growth Stocks to Buy for February 2023 ↗
Some of the best growth stocks are lesser-known names that have the ability to provide tremendous long-term upside for investors. 
Via InvestorPlace
News headline image
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review ↗
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
News headline image
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed? ↗
Things aren't as bad as they might seem. 
Via The Motley Fool
News headline image
6 Great Stocks to Buy in 2023 and Hold Forever ↗
I own all six great businesses and don't plan to sell a single share. 
Via The Motley Fool
News headline image
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback ↗
Catalyst is adding to its portfolio with a $160 million deal. 
Via Investor's Business Daily
News headline image
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025 ↗
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals. 
Via The Motley Fool
News headline image
Dow, Nasdaq Boasting Triple-Digit Midday Lead ↗
Investors seem intent on leaving last week's losses behind, as earnings season heats up. 
Via Talk Markets
News headline image
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product ↗
 
Via Benzinga
News headline image
Analyst Ratings for Teva Pharmaceutical Indus ↗
 
Via Benzinga
News headline image
3 Dirt Cheap Stocks to Buy in January ↗
Bargains can easily be found as the new year gets underway. 
Via The Motley Fool
News headline image
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product ↗
Shares have sat atop the IBD 50 for weeks, have perfect ratings and recently hit a profit-taking zone. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023 ↗
 
Via Benzinga
News headline image
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
News headline image
Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
News headline image
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today ↗
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool
News headline image
Most Active Equity Options For Midday - Wednesday, Jan. 11 ↗
Here are the most active equity options for midday. 
Via Talk Markets
News headline image
NVAX Stock Alert: What to Know as Novavax Names New CEO ↗
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
News headline image
4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now ↗
These all handily outperformed the market last year and could do the same in 2023. 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court ↗
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE ↗
While the tenor was more bearish, the late-day rally found the market close to where it finished 2022. 
Via Talk Markets
News headline image
2 "Safe" Stocks That Are Anything But ↗
Sometimes, business models that sound safe still fail to deliver for shareholders. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
My Top 5 Portfolio Holdings for 2023 ↗
This mix of growth and value stocks can outperform in a challenging environment. 
Via The Motley Fool
News headline image
Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity ↗
Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.